257 related articles for article (PubMed ID: 35011339)
1. Insights into Structural Modifications of Valproic Acid and Their Pharmacological Profile.
Mishra MK; Kukal S; Paul PR; Bora S; Singh A; Kukreti S; Saso L; Muthusamy K; Hasija Y; Kukreti R
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011339
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of antiallodynic and anticonvulsant activity of novel amide and urea derivatives of valproic acid analogues.
Kaufmann D; Bialer M; Shimshoni JA; Devor M; Yagen B
J Med Chem; 2009 Nov; 52(22):7236-48. PubMed ID: 19877649
[TBL] [Abstract][Full Text] [Related]
3. Potent anticonvulsant urea derivatives of constitutional isomers of valproic acid.
Shimshoni JA; Bialer M; Wlodarczyk B; Finnell RH; Yagen B
J Med Chem; 2007 Dec; 50(25):6419-27. PubMed ID: 17994680
[TBL] [Abstract][Full Text] [Related]
4. Anticonvulsant profile and teratogenic evaluation of potent new analogues of a valproic acid urea derivative in NMRI mice.
Okada A; Noyori H; Yagen B; Shimshoni JA; Bialer M; Fujiwara M
Birth Defects Res B Dev Reprod Toxicol; 2009 Oct; 86(5):394-401. PubMed ID: 19830722
[TBL] [Abstract][Full Text] [Related]
5. Structure-function studies for the panacea, valproic acid.
Terbach N; Williams RS
Biochem Soc Trans; 2009 Oct; 37(Pt 5):1126-32. PubMed ID: 19754465
[TBL] [Abstract][Full Text] [Related]
6. New CNS-active drugs which are second-generation valproic acid: can they lead to the development of a magic bullet?
Isoherranen N; Yagen B; Bialer M
Curr Opin Neurol; 2003 Apr; 16(2):203-11. PubMed ID: 12644750
[TBL] [Abstract][Full Text] [Related]
7. Valproic Acid: second generation.
Bialer M; Yagen B
Neurotherapeutics; 2007 Jan; 4(1):130-7. PubMed ID: 17199028
[TBL] [Abstract][Full Text] [Related]
8. Tetramethylcyclopropyl analogue of the leading antiepileptic drug, valproic acid: evaluation of the teratogenic effects of its amide derivatives in NMRI mice.
Okada A; Onishi Y; Yagen B; Shimshoni JA; Kaufmann D; Bialer M; Fujiwara M
Birth Defects Res A Clin Mol Teratol; 2008 Sep; 82(9):610-21. PubMed ID: 18671279
[TBL] [Abstract][Full Text] [Related]
9. Hydroxamic acid and fluorinated derivatives of valproic acid: anticonvulsant activity, neurotoxicity and teratogenicity.
Gravemann U; Volland J; Nau H
Neurotoxicol Teratol; 2008; 30(5):390-4. PubMed ID: 18455366
[TBL] [Abstract][Full Text] [Related]
10. Further branching of valproate-related carboxylic acids reduces the teratogenic activity, but not the anticonvulsant effect.
Bojic U; Elmazar MM; Hauck RS; Nau H
Chem Res Toxicol; 1996; 9(5):866-70. PubMed ID: 8828922
[TBL] [Abstract][Full Text] [Related]
11. Valproate: past, present, and future.
Johannessen CU; Johannessen SI
CNS Drug Rev; 2003; 9(2):199-216. PubMed ID: 12847559
[TBL] [Abstract][Full Text] [Related]
12. Tetramethylcyclopropyl analogue of a leading antiepileptic drug, valproic acid. Synthesis and evaluation of anticonvulsant activity of its amide derivatives.
Sobol E; Bialer M; Yagen B
J Med Chem; 2004 Aug; 47(17):4316-26. PubMed ID: 15294003
[TBL] [Abstract][Full Text] [Related]
13. Prediction of embryotoxic effects of valproic acid-derivatives with molecular in vitro methods.
Lampen A; Göttlicher M; Nau H
ALTEX; 2001; 18(2):123-6. PubMed ID: 11378687
[TBL] [Abstract][Full Text] [Related]
14. Effects of valproic acid derivatives on inositol trisphosphate depletion, teratogenicity, glycogen synthase kinase-3beta inhibition, and viral replication: a screening approach for new bipolar disorder drugs derived from the valproic acid core structure.
Eickholt BJ; Towers GJ; Ryves WJ; Eikel D; Adley K; Ylinen LM; Chadborn NH; Harwood AJ; Nau H; Williams RS
Mol Pharmacol; 2005 May; 67(5):1426-33. PubMed ID: 15687223
[TBL] [Abstract][Full Text] [Related]
15. Can we develop improved derivatives of valproic acid?
Bialer M; Haj-Yehia A; Badir K; Hadad S
Pharm World Sci; 1994 Feb; 16(1):2-6. PubMed ID: 8156045
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of stereoselective anticonvulsant, teratogenic, and pharmacokinetic profile of valnoctylurea (capuride): a chiral stereoisomer of valproic acid urea derivative.
Shimshoni JA; Yagen B; Wlodarczyk B; Finnell RH; Schurig V; Bialer M
Epilepsia; 2010 Mar; 51(3):323-32. PubMed ID: 19674061
[TBL] [Abstract][Full Text] [Related]
17. A new derivative of valproic acid amide possesses a broad-spectrum antiseizure profile and unique activity against status epilepticus and organophosphate neuronal damage.
White HS; Alex AB; Pollock A; Hen N; Shekh-Ahmad T; Wilcox KS; McDonough JH; Stables JP; Kaufmann D; Yagen B; Bialer M
Epilepsia; 2012 Jan; 53(1):134-46. PubMed ID: 22150444
[TBL] [Abstract][Full Text] [Related]
18. Effects of valproate derivatives I. Antiepileptic efficacy of amides, structural analogs and esters.
Redecker C; Altrup U; Hoppe D; Düsing R; Speckmann EJ
Neuropharmacology; 2000 Jan; 39(2):254-66. PubMed ID: 10670421
[TBL] [Abstract][Full Text] [Related]
19. Preliminary evaluation of the anticonvulsant activity of a valproic acid analog: N-(2-propylpentanoyl) urea.
Tantisira B; Tantisira MH; Patarapanich C; Sooksawate T; Chunngam T
Res Commun Mol Pathol Pharmacol; 1997 Aug; 97(2):151-64. PubMed ID: 9344228
[TBL] [Abstract][Full Text] [Related]
20. The effects of central nervous system-active valproic acid constitutional isomers, cyclopropyl analogs, and amide derivatives on neuronal growth cone behavior.
Shimshoni JA; Dalton EC; Jenkins A; Eyal S; Ewan K; Williams RS; Pessah N; Yagen B; Harwood AJ; Bialer M
Mol Pharmacol; 2007 Mar; 71(3):884-92. PubMed ID: 17167030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
